These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3167558)
1. [3H]GBR-12935 binding to dopamine uptake sites in the human brain. Marcusson J; Eriksson K Brain Res; 1988 Aug; 457(1):122-9. PubMed ID: 3167558 [TBL] [Abstract][Full Text] [Related]
2. [3H]GBR-12935 binding to dopamine uptake sites in rat striatum. Allard PO; Eriksson K; Ross SB; Marcusson JO Neuropsychobiology; 1990-1991; 23(4):177-81. PubMed ID: 2130286 [TBL] [Abstract][Full Text] [Related]
3. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics. Richfield EK Brain Res; 1991 Feb; 540(1-2):1-13. PubMed ID: 1829013 [TBL] [Abstract][Full Text] [Related]
4. Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935. Reith ME; Selmeci G Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):309-18. PubMed ID: 1620235 [TBL] [Abstract][Full Text] [Related]
5. Autoradiographic localization of dopamine uptake sites in the rat brain with 3H-GBR 12935. Mennicken F; Savasta M; Peretti-Renucci R; Feuerstein C J Neural Transm Gen Sect; 1992; 87(1):1-14. PubMed ID: 1346964 [TBL] [Abstract][Full Text] [Related]
6. [3H]GBR 12935 binding to dopamine uptake sites in the human brain. De Keyser J; De Backer JP; Ebinger G; Vauquelin G J Neurochem; 1989 Nov; 53(5):1400-4. PubMed ID: 2795007 [TBL] [Abstract][Full Text] [Related]
7. Characterization of binding of [3H]GBR 12935 (1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-piperazine) to membranes and to solubilized membrane extracts from terminal field regions of mesolimbic, mesocortical and nigrostriatal dopamine pathways. Izenwasser S; Werling LL; Rosenberger JG; Cox BM Neuropharmacology; 1990 Nov; 29(11):1017-24. PubMed ID: 2087254 [TBL] [Abstract][Full Text] [Related]
8. [3H]GBR-12935 binding to human cerebral cortex is not to dopamine uptake sites. Allard P; Danielsson M; Papworth K; Marcusson JO J Neurochem; 1994 Jan; 62(1):338-41. PubMed ID: 8263533 [TBL] [Abstract][Full Text] [Related]
9. Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol. Bonnet JJ; Benmansour S; Costentin J; Parker EM; Cubeddu LX J Pharmacol Exp Ther; 1990 Jun; 253(3):1206-14. PubMed ID: 2141637 [TBL] [Abstract][Full Text] [Related]
10. High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system. Bonnet JJ; Protais P; Chagraoui A; Costentin J Eur J Pharmacol; 1986 Jul; 126(3):211-22. PubMed ID: 3489625 [TBL] [Abstract][Full Text] [Related]
12. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins. Niznik HB; Tyndale RF; Sallee FR; Gonzalez FJ; Hardwick JP; Inaba T; Kalow W Arch Biochem Biophys; 1990 Feb; 276(2):424-32. PubMed ID: 2306106 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding. Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271 [TBL] [Abstract][Full Text] [Related]
14. Biochemical and pharmacological characterization of [3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex. Andersen PH J Neurochem; 1987 Jun; 48(6):1887-96. PubMed ID: 2952763 [TBL] [Abstract][Full Text] [Related]
15. The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus. Niznik HB; Fogel EF; Fassos FF; Seeman P J Neurochem; 1991 Jan; 56(1):192-8. PubMed ID: 1987318 [TBL] [Abstract][Full Text] [Related]
16. Interaction of two sulfhydryl reagents with a cation recognition site on the neuronal dopamine carrier evidences small differences between [3H]GBR 12783 and [3H]cocaine binding sites. Refahi-Lyamani F; Saadouni S; Costentin J; Bonnet JJ Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):136-45. PubMed ID: 7770096 [TBL] [Abstract][Full Text] [Related]
17. [3H]GBR-12935 binding sites in human striatal membranes: binding characteristics and changes in parkinsonians and schizophrenics. Hirai M; Kitamura N; Hashimoto T; Nakai T; Mita T; Shirakawa O; Yamadori T; Amano T; Noguchi-Kuno SA; Tanaka C Jpn J Pharmacol; 1988 Jul; 47(3):237-43. PubMed ID: 3221529 [TBL] [Abstract][Full Text] [Related]
18. The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action. Andersen PH Eur J Pharmacol; 1989 Aug; 166(3):493-504. PubMed ID: 2530094 [TBL] [Abstract][Full Text] [Related]
19. [3H]GBR-12935 binding to cytochrome P450 in the human brain. Allard P; Marcusson JO; Ross SB J Neurochem; 1994 Jan; 62(1):342-8. PubMed ID: 8263534 [TBL] [Abstract][Full Text] [Related]
20. [3H]GBR 12935 binding to human platelet membranes is sensitive to piperazine derivatives but not to dopamine uptake inhibitors. Gordon I; Weizman R; Rehavi M Life Sci; 1994; 55(3):189-99. PubMed ID: 8007761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]